229 related articles for article (PubMed ID: 32131813)
1. Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells.
Dunican DS; Mjoseng HK; Duthie L; Flyamer IM; Bickmore WA; Meehan RR
BMC Biol; 2020 Mar; 18(1):25. PubMed ID: 32131813
[TBL] [Abstract][Full Text] [Related]
2. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
Court F; Arnaud P
Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
[TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeling and bivalent histone modifications in embryonic stem cells.
Harikumar A; Meshorer E
EMBO Rep; 2015 Dec; 16(12):1609-19. PubMed ID: 26553936
[TBL] [Abstract][Full Text] [Related]
4. H4K20me3 co-localizes with activating histone modifications at transcriptionally dynamic regions in embryonic stem cells.
Xu J; Kidder BL
BMC Genomics; 2018 Jul; 19(1):514. PubMed ID: 29969988
[TBL] [Abstract][Full Text] [Related]
5. CpG island erosion, polycomb occupancy and sequence motif enrichment at bivalent promoters in mammalian embryonic stem cells.
Mantsoki A; Devailly G; Joshi A
Sci Rep; 2015 Nov; 5():16791. PubMed ID: 26582124
[TBL] [Abstract][Full Text] [Related]
6. Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells.
King AD; Huang K; Rubbi L; Liu S; Wang CY; Wang Y; Pellegrini M; Fan G
Cell Rep; 2016 Sep; 17(1):289-302. PubMed ID: 27681438
[TBL] [Abstract][Full Text] [Related]
7. A double take on bivalent promoters.
Voigt P; Tee WW; Reinberg D
Genes Dev; 2013 Jun; 27(12):1318-38. PubMed ID: 23788621
[TBL] [Abstract][Full Text] [Related]
8. Decoding the function of bivalent chromatin in development and cancer.
Kumar D; Cinghu S; Oldfield AJ; Yang P; Jothi R
Genome Res; 2021 Dec; 31(12):2170-2184. PubMed ID: 34667120
[TBL] [Abstract][Full Text] [Related]
9. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
10. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells.
Gu T; Lin X; Cullen SM; Luo M; Jeong M; Estecio M; Shen J; Hardikar S; Sun D; Su J; Rux D; Guzman A; Lee M; Qi LS; Chen JJ; Kyba M; Huang Y; Chen T; Li W; Goodell MA
Genome Biol; 2018 Jul; 19(1):88. PubMed ID: 30001199
[TBL] [Abstract][Full Text] [Related]
11. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Multiplexed ChIP Reveals Global Alterations that Shape Promoter Bivalency in Ground State Embryonic Stem Cells.
Kumar B; Elsässer SJ
Cell Rep; 2019 Sep; 28(12):3274-3284.e5. PubMed ID: 31533047
[TBL] [Abstract][Full Text] [Related]
13. A low-input high resolution sequential chromatin immunoprecipitation method captures genome-wide dynamics of bivalent chromatin.
Seneviratne JA; Ho WWH; Glancy E; Eckersley-Maslin MA
Epigenetics Chromatin; 2024 Feb; 17(1):3. PubMed ID: 38336688
[TBL] [Abstract][Full Text] [Related]
14. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.
Denissov S; Hofemeister H; Marks H; Kranz A; Ciotta G; Singh S; Anastassiadis K; Stunnenberg HG; Stewart AF
Development; 2014 Feb; 141(3):526-37. PubMed ID: 24423662
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Studies Reveal that H3K4me3 Modification in Bivalent Genes Is Dynamically Regulated during the Pluripotent Cell Cycle and Stabilized upon Differentiation.
Grandy RA; Whitfield TW; Wu H; Fitzgerald MP; VanOudenhove JJ; Zaidi SK; Montecino MA; Lian JB; van Wijnen AJ; Stein JL; Stein GS
Mol Cell Biol; 2016 Feb; 36(4):615-27. PubMed ID: 26644406
[TBL] [Abstract][Full Text] [Related]
16. The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells.
Hu D; Garruss AS; Gao X; Morgan MA; Cook M; Smith ER; Shilatifard A
Nat Struct Mol Biol; 2013 Sep; 20(9):1093-7. PubMed ID: 23934151
[TBL] [Abstract][Full Text] [Related]
17. H3K27me3-H3K4me1 transition at bivalent promoters instructs lineage specification in development.
Yu Y; Li X; Jiao R; Lu Y; Jiang X; Li X
Cell Biosci; 2023 Mar; 13(1):66. PubMed ID: 36991495
[TBL] [Abstract][Full Text] [Related]
18. Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome.
Putiri EL; Tiedemann RL; Liu C; Choi JH; Robertson KD
Oncotarget; 2014 Aug; 5(15):6338-52. PubMed ID: 25071008
[TBL] [Abstract][Full Text] [Related]
19. DNMT3B shapes the mCA landscape and regulates mCG for promoter bivalency in human embryonic stem cells.
Tan HK; Wu CS; Li J; Tan ZH; Hoffman JR; Fry CJ; Yang H; Di Ruscio A; Tenen DG
Nucleic Acids Res; 2019 Aug; 47(14):7460-7475. PubMed ID: 31219573
[TBL] [Abstract][Full Text] [Related]
20. Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs.
Muñoa-Hoyos I; Halsall JA; Araolaza M; Ward C; Garcia I; Urizar-Arenaza I; Gianzo M; Garcia P; Turner B; Subirán N
Clin Epigenetics; 2020 Nov; 12(1):170. PubMed ID: 33168052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
